The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $73.44

Today's change-0.92 -1.24%
Updated March 26 4:01 PM EDT. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $73.44

Today's change-0.92 -1.24%
Updated March 26 4:01 PM EDT. Delayed by at least 15 minutes.

Eli Lilly and Co down (U.S.)$0.92

Eli Lilly and Co closed lower Thursday, dropping (U.S.)$0.92 or 1.24% to (U.S.)$73.44. Shares have lost 1.05% over the last five days, but have gained 6.45% over the last year to date. This security has outperformed the S&P 500 by 16.78% during the last year.

Key company metrics

  • Open(U.S.) $74.00
  • Previous close(U.S.) $74.36
  • High(U.S.) $74.35
  • Low(U.S.) $73.42
  • Bid / Ask(U.S.) $73.30 / (U.S.) $76.90
  • YTD % change+6.45%
  • Volume4,023,488
  • Average volume (10-day)5,638,603
  • Average volume (1-month)4,581,799
  • Average volume (3-month)4,438,342
  • 52-week range(U.S.) $57.17 to (U.S.) $77.46
  • Beta0.37
  • Trailing P/E33.02×
  • P/E 1 year forward23.52×
  • Forward PEG4.16×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.72%
  • Trailing EPS(U.S.) $2.22
Updated March 26 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.19%

Based on its net profit margin of 12.19%, Eli Lilly and Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue5,1214,8764,9364,683
Total other revenue--------
Total revenue5,1214,8764,9364,683
Gross profit3,8683,6093,7463,460
Total cost of revenue1,2531,2671,1901,223
Total operating expense4,7454,3144,0493,848
Selling / general / administrative1,8001,6721,6641,485
Research & development1,1861,2431,1951,109
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)506131031
Other operating expenses, total--------
Operating income376562887835
Interest income (expense), net non-operating-49-48-45-46
Gain (loss) on sale of assets--------
Other--------
Income before tax514656940891
Income after tax429501734728
Income tax, total85155207163
Net income429501734728
Total adjustments to net income--------
Net income before extra. items429501734728
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items429501734728
Inc. avail. to common incl. extra. items429501734728
Diluted net income429501734728
Dilution adjustment--------
Diluted weighted average shares1,0701,0741,0761,076
Diluted EPS excluding extraordinary itemsvalue per share0.400.470.680.68
Dividends per sharevalue per share0.490.490.490.49
Diluted normalized EPSvalue per share0.810.580.680.70